Global Recombinant DNA Technology Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Recombinant DNA Technology Industry Forecast” looks at past sales and reviews total world Recombinant DNA Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant DNA Technology sales for 2023 through 2029. With Recombinant DNA Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant DNA Technology industry.
This Insight Report provides a comprehensive analysis of the global Recombinant DNA Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant DNA Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant DNA Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant DNA Technology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant DNA Technology.
The global Recombinant DNA Technology market size is projected to grow from US$ 480.1 million in 2022 to US$ 634.3 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
United States market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant DNA Technology players cover Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant DNA Technology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Recombinant DNA Technology Industry Forecast” looks at past sales and reviews total world Recombinant DNA Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant DNA Technology sales for 2023 through 2029. With Recombinant DNA Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant DNA Technology industry.
This Insight Report provides a comprehensive analysis of the global Recombinant DNA Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant DNA Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant DNA Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant DNA Technology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant DNA Technology.
The global Recombinant DNA Technology market size is projected to grow from US$ 480.1 million in 2022 to US$ 634.3 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
United States market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant DNA Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant DNA Technology players cover Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant DNA Technology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Therapeutic Agent
- Vaccine
- Biotech Crops
- Specialty Chemicals
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Monsanto Company
- Roche
- Biogen
- Amgen
- Novartis
- Eli Lilly and Company
- GenScript
- Pfizer Inc.
- Novo Nordisk
- Sanofi
- Merck KGaA
- Profacgen
- Biocon
- GlaxoSmithKline
- Cibus
- Horizon Discovery Group
- New England Biolabs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant DNA Technology Market Size 2018-2029
2.1.2 Recombinant DNA Technology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Recombinant DNA Technology Segment by Type
2.2.1 Therapeutic Agent
2.2.2 Vaccine
2.2.3 Biotech Crops
2.2.4 Specialty Chemicals
2.3 Recombinant DNA Technology Market Size by Type
2.3.1 Recombinant DNA Technology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
2.4 Recombinant DNA Technology Segment by Application
2.4.1 Biotechnology and Pharmaceutical Companies
2.4.2 Academic & Government Research Institutes
2.4.3 Others
2.5 Recombinant DNA Technology Market Size by Application
2.5.1 Recombinant DNA Technology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
3 RECOMBINANT DNA TECHNOLOGY MARKET SIZE BY PLAYER
3.1 Recombinant DNA Technology Market Size Market Share by Players
3.1.1 Global Recombinant DNA Technology Revenue by Players (2018-2023)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant DNA Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA TECHNOLOGY BY REGIONS
4.1 Recombinant DNA Technology Market Size by Regions (2018-2023)
4.2 Americas Recombinant DNA Technology Market Size Growth (2018-2023)
4.3 APAC Recombinant DNA Technology Market Size Growth (2018-2023)
4.4 Europe Recombinant DNA Technology Market Size Growth (2018-2023)
4.5 Middle East & Africa Recombinant DNA Technology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Recombinant DNA Technology Market Size by Country (2018-2023)
5.2 Americas Recombinant DNA Technology Market Size by Type (2018-2023)
5.3 Americas Recombinant DNA Technology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant DNA Technology Market Size by Region (2018-2023)
6.2 APAC Recombinant DNA Technology Market Size by Type (2018-2023)
6.3 APAC Recombinant DNA Technology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant DNA Technology by Country (2018-2023)
7.2 Europe Recombinant DNA Technology Market Size by Type (2018-2023)
7.3 Europe Recombinant DNA Technology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant DNA Technology by Region (2018-2023)
8.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2018-2023)
8.3 Middle East & Africa Recombinant DNA Technology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET FORECAST
10.1 Global Recombinant DNA Technology Forecast by Regions (2024-2029)
10.1.1 Global Recombinant DNA Technology Forecast by Regions (2024-2029)
10.1.2 Americas Recombinant DNA Technology Forecast
10.1.3 APAC Recombinant DNA Technology Forecast
10.1.4 Europe Recombinant DNA Technology Forecast
10.1.5 Middle East & Africa Recombinant DNA Technology Forecast
10.2 Americas Recombinant DNA Technology Forecast by Country (2024-2029)
10.2.1 United States Recombinant DNA Technology Market Forecast
10.2.2 Canada Recombinant DNA Technology Market Forecast
10.2.3 Mexico Recombinant DNA Technology Market Forecast
10.2.4 Brazil Recombinant DNA Technology Market Forecast
10.3 APAC Recombinant DNA Technology Forecast by Region (2024-2029)
10.3.1 China Recombinant DNA Technology Market Forecast
10.3.2 Japan Recombinant DNA Technology Market Forecast
10.3.3 Korea Recombinant DNA Technology Market Forecast
10.3.4 Southeast Asia Recombinant DNA Technology Market Forecast
10.3.5 India Recombinant DNA Technology Market Forecast
10.3.6 Australia Recombinant DNA Technology Market Forecast
10.4 Europe Recombinant DNA Technology Forecast by Country (2024-2029)
10.4.1 Germany Recombinant DNA Technology Market Forecast
10.4.2 France Recombinant DNA Technology Market Forecast
10.4.3 UK Recombinant DNA Technology Market Forecast
10.4.4 Italy Recombinant DNA Technology Market Forecast
10.4.5 Russia Recombinant DNA Technology Market Forecast
10.5 Middle East & Africa Recombinant DNA Technology Forecast by Region (2024-2029)
10.5.1 Egypt Recombinant DNA Technology Market Forecast
10.5.2 South Africa Recombinant DNA Technology Market Forecast
10.5.3 Israel Recombinant DNA Technology Market Forecast
10.5.4 Turkey Recombinant DNA Technology Market Forecast
10.5.5 GCC Countries Recombinant DNA Technology Market Forecast
10.6 Global Recombinant DNA Technology Forecast by Type (2024-2029)
10.7 Global Recombinant DNA Technology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Monsanto Company
11.1.1 Monsanto Company Company Information
11.1.2 Monsanto Company Recombinant DNA Technology Product Offered
11.1.3 Monsanto Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Monsanto Company Main Business Overview
11.1.5 Monsanto Company Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Recombinant DNA Technology Product Offered
11.2.3 Roche Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Recombinant DNA Technology Product Offered
11.3.3 Biogen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Biogen Main Business Overview
11.3.5 Biogen Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Recombinant DNA Technology Product Offered
11.4.3 Amgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Recombinant DNA Technology Product Offered
11.5.3 Novartis Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Information
11.6.2 Eli Lilly and Company Recombinant DNA Technology Product Offered
11.6.3 Eli Lilly and Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Eli Lilly and Company Main Business Overview
11.6.5 Eli Lilly and Company Latest Developments
11.7 GenScript
11.7.1 GenScript Company Information
11.7.2 GenScript Recombinant DNA Technology Product Offered
11.7.3 GenScript Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GenScript Main Business Overview
11.7.5 GenScript Latest Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Information
11.8.2 Pfizer Inc. Recombinant DNA Technology Product Offered
11.8.3 Pfizer Inc. Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pfizer Inc. Main Business Overview
11.8.5 Pfizer Inc. Latest Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Information
11.9.2 Novo Nordisk Recombinant DNA Technology Product Offered
11.9.3 Novo Nordisk Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novo Nordisk Main Business Overview
11.9.5 Novo Nordisk Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Recombinant DNA Technology Product Offered
11.10.3 Sanofi Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Recombinant DNA Technology Product Offered
11.11.3 Merck KGaA Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Profacgen
11.12.1 Profacgen Company Information
11.12.2 Profacgen Recombinant DNA Technology Product Offered
11.12.3 Profacgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Profacgen Main Business Overview
11.12.5 Profacgen Latest Developments
11.13 Biocon
11.13.1 Biocon Company Information
11.13.2 Biocon Recombinant DNA Technology Product Offered
11.13.3 Biocon Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biocon Main Business Overview
11.13.5 Biocon Latest Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Information
11.14.2 GlaxoSmithKline Recombinant DNA Technology Product Offered
11.14.3 GlaxoSmithKline Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 GlaxoSmithKline Main Business Overview
11.14.5 GlaxoSmithKline Latest Developments
11.15 Cibus
11.15.1 Cibus Company Information
11.15.2 Cibus Recombinant DNA Technology Product Offered
11.15.3 Cibus Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cibus Main Business Overview
11.15.5 Cibus Latest Developments
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Information
11.16.2 Horizon Discovery Group Recombinant DNA Technology Product Offered
11.16.3 Horizon Discovery Group Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Horizon Discovery Group Main Business Overview
11.16.5 Horizon Discovery Group Latest Developments
11.17 New England Biolabs
11.17.1 New England Biolabs Company Information
11.17.2 New England Biolabs Recombinant DNA Technology Product Offered
11.17.3 New England Biolabs Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 New England Biolabs Main Business Overview
11.17.5 New England Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant DNA Technology Market Size 2018-2029
2.1.2 Recombinant DNA Technology Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Recombinant DNA Technology Segment by Type
2.2.1 Therapeutic Agent
2.2.2 Vaccine
2.2.3 Biotech Crops
2.2.4 Specialty Chemicals
2.3 Recombinant DNA Technology Market Size by Type
2.3.1 Recombinant DNA Technology Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
2.4 Recombinant DNA Technology Segment by Application
2.4.1 Biotechnology and Pharmaceutical Companies
2.4.2 Academic & Government Research Institutes
2.4.3 Others
2.5 Recombinant DNA Technology Market Size by Application
2.5.1 Recombinant DNA Technology Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
3 RECOMBINANT DNA TECHNOLOGY MARKET SIZE BY PLAYER
3.1 Recombinant DNA Technology Market Size Market Share by Players
3.1.1 Global Recombinant DNA Technology Revenue by Players (2018-2023)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant DNA Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RECOMBINANT DNA TECHNOLOGY BY REGIONS
4.1 Recombinant DNA Technology Market Size by Regions (2018-2023)
4.2 Americas Recombinant DNA Technology Market Size Growth (2018-2023)
4.3 APAC Recombinant DNA Technology Market Size Growth (2018-2023)
4.4 Europe Recombinant DNA Technology Market Size Growth (2018-2023)
4.5 Middle East & Africa Recombinant DNA Technology Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Recombinant DNA Technology Market Size by Country (2018-2023)
5.2 Americas Recombinant DNA Technology Market Size by Type (2018-2023)
5.3 Americas Recombinant DNA Technology Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant DNA Technology Market Size by Region (2018-2023)
6.2 APAC Recombinant DNA Technology Market Size by Type (2018-2023)
6.3 APAC Recombinant DNA Technology Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Recombinant DNA Technology by Country (2018-2023)
7.2 Europe Recombinant DNA Technology Market Size by Type (2018-2023)
7.3 Europe Recombinant DNA Technology Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant DNA Technology by Region (2018-2023)
8.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2018-2023)
8.3 Middle East & Africa Recombinant DNA Technology Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RECOMBINANT DNA TECHNOLOGY MARKET FORECAST
10.1 Global Recombinant DNA Technology Forecast by Regions (2024-2029)
10.1.1 Global Recombinant DNA Technology Forecast by Regions (2024-2029)
10.1.2 Americas Recombinant DNA Technology Forecast
10.1.3 APAC Recombinant DNA Technology Forecast
10.1.4 Europe Recombinant DNA Technology Forecast
10.1.5 Middle East & Africa Recombinant DNA Technology Forecast
10.2 Americas Recombinant DNA Technology Forecast by Country (2024-2029)
10.2.1 United States Recombinant DNA Technology Market Forecast
10.2.2 Canada Recombinant DNA Technology Market Forecast
10.2.3 Mexico Recombinant DNA Technology Market Forecast
10.2.4 Brazil Recombinant DNA Technology Market Forecast
10.3 APAC Recombinant DNA Technology Forecast by Region (2024-2029)
10.3.1 China Recombinant DNA Technology Market Forecast
10.3.2 Japan Recombinant DNA Technology Market Forecast
10.3.3 Korea Recombinant DNA Technology Market Forecast
10.3.4 Southeast Asia Recombinant DNA Technology Market Forecast
10.3.5 India Recombinant DNA Technology Market Forecast
10.3.6 Australia Recombinant DNA Technology Market Forecast
10.4 Europe Recombinant DNA Technology Forecast by Country (2024-2029)
10.4.1 Germany Recombinant DNA Technology Market Forecast
10.4.2 France Recombinant DNA Technology Market Forecast
10.4.3 UK Recombinant DNA Technology Market Forecast
10.4.4 Italy Recombinant DNA Technology Market Forecast
10.4.5 Russia Recombinant DNA Technology Market Forecast
10.5 Middle East & Africa Recombinant DNA Technology Forecast by Region (2024-2029)
10.5.1 Egypt Recombinant DNA Technology Market Forecast
10.5.2 South Africa Recombinant DNA Technology Market Forecast
10.5.3 Israel Recombinant DNA Technology Market Forecast
10.5.4 Turkey Recombinant DNA Technology Market Forecast
10.5.5 GCC Countries Recombinant DNA Technology Market Forecast
10.6 Global Recombinant DNA Technology Forecast by Type (2024-2029)
10.7 Global Recombinant DNA Technology Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Monsanto Company
11.1.1 Monsanto Company Company Information
11.1.2 Monsanto Company Recombinant DNA Technology Product Offered
11.1.3 Monsanto Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Monsanto Company Main Business Overview
11.1.5 Monsanto Company Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Recombinant DNA Technology Product Offered
11.2.3 Roche Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Recombinant DNA Technology Product Offered
11.3.3 Biogen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Biogen Main Business Overview
11.3.5 Biogen Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Recombinant DNA Technology Product Offered
11.4.3 Amgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Recombinant DNA Technology Product Offered
11.5.3 Novartis Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Information
11.6.2 Eli Lilly and Company Recombinant DNA Technology Product Offered
11.6.3 Eli Lilly and Company Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Eli Lilly and Company Main Business Overview
11.6.5 Eli Lilly and Company Latest Developments
11.7 GenScript
11.7.1 GenScript Company Information
11.7.2 GenScript Recombinant DNA Technology Product Offered
11.7.3 GenScript Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GenScript Main Business Overview
11.7.5 GenScript Latest Developments
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Information
11.8.2 Pfizer Inc. Recombinant DNA Technology Product Offered
11.8.3 Pfizer Inc. Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pfizer Inc. Main Business Overview
11.8.5 Pfizer Inc. Latest Developments
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Information
11.9.2 Novo Nordisk Recombinant DNA Technology Product Offered
11.9.3 Novo Nordisk Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novo Nordisk Main Business Overview
11.9.5 Novo Nordisk Latest Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Recombinant DNA Technology Product Offered
11.10.3 Sanofi Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sanofi Main Business Overview
11.10.5 Sanofi Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Recombinant DNA Technology Product Offered
11.11.3 Merck KGaA Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Profacgen
11.12.1 Profacgen Company Information
11.12.2 Profacgen Recombinant DNA Technology Product Offered
11.12.3 Profacgen Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Profacgen Main Business Overview
11.12.5 Profacgen Latest Developments
11.13 Biocon
11.13.1 Biocon Company Information
11.13.2 Biocon Recombinant DNA Technology Product Offered
11.13.3 Biocon Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Biocon Main Business Overview
11.13.5 Biocon Latest Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Information
11.14.2 GlaxoSmithKline Recombinant DNA Technology Product Offered
11.14.3 GlaxoSmithKline Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 GlaxoSmithKline Main Business Overview
11.14.5 GlaxoSmithKline Latest Developments
11.15 Cibus
11.15.1 Cibus Company Information
11.15.2 Cibus Recombinant DNA Technology Product Offered
11.15.3 Cibus Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Cibus Main Business Overview
11.15.5 Cibus Latest Developments
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Information
11.16.2 Horizon Discovery Group Recombinant DNA Technology Product Offered
11.16.3 Horizon Discovery Group Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Horizon Discovery Group Main Business Overview
11.16.5 Horizon Discovery Group Latest Developments
11.17 New England Biolabs
11.17.1 New England Biolabs Company Information
11.17.2 New England Biolabs Recombinant DNA Technology Product Offered
11.17.3 New England Biolabs Recombinant DNA Technology Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 New England Biolabs Main Business Overview
11.17.5 New England Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant DNA Technology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Therapeutic Agent
Table 3. Major Players of Vaccine
Table 4. Major Players of Biotech Crops
Table 5. Major Players of Specialty Chemicals
Table 6. Recombinant DNA Technology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 9. Recombinant DNA Technology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 12. Global Recombinant DNA Technology Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Recombinant DNA Technology Revenue Market Share by Player (2018-2023)
Table 14. Recombinant DNA Technology Key Players Head office and Products Offered
Table 15. Recombinant DNA Technology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Recombinant DNA Technology Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Recombinant DNA Technology Market Size Market Share by Regions (2018-2023)
Table 20. Global Recombinant DNA Technology Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Recombinant DNA Technology Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Recombinant DNA Technology Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Recombinant DNA Technology Market Size Market Share by Country (2018-2023)
Table 24. Americas Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 26. Americas Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 28. APAC Recombinant DNA Technology Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Table 30. APAC Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 32. APAC Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 34. Europe Recombinant DNA Technology Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Recombinant DNA Technology Market Size Market Share by Country (2018-2023)
Table 36. Europe Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 38. Europe Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Recombinant DNA Technology Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Recombinant DNA Technology
Table 47. Key Market Challenges & Risks of Recombinant DNA Technology
Table 48. Key Industry Trends of Recombinant DNA Technology
Table 49. Global Recombinant DNA Technology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Recombinant DNA Technology Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Recombinant DNA Technology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Recombinant DNA Technology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Monsanto Company Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 54. Monsanto Company Recombinant DNA Technology Product Offered
Table 55. Monsanto Company Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Monsanto Company Main Business
Table 57. Monsanto Company Latest Developments
Table 58. Roche Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 59. Roche Recombinant DNA Technology Product Offered
Table 60. Roche Main Business
Table 61. Roche Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Roche Latest Developments
Table 63. Biogen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 64. Biogen Recombinant DNA Technology Product Offered
Table 65. Biogen Main Business
Table 66. Biogen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Biogen Latest Developments
Table 68. Amgen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 69. Amgen Recombinant DNA Technology Product Offered
Table 70. Amgen Main Business
Table 71. Amgen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Amgen Latest Developments
Table 73. Novartis Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 74. Novartis Recombinant DNA Technology Product Offered
Table 75. Novartis Main Business
Table 76. Novartis Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Latest Developments
Table 78. Eli Lilly and Company Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 79. Eli Lilly and Company Recombinant DNA Technology Product Offered
Table 80. Eli Lilly and Company Main Business
Table 81. Eli Lilly and Company Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Eli Lilly and Company Latest Developments
Table 83. GenScript Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 84. GenScript Recombinant DNA Technology Product Offered
Table 85. GenScript Main Business
Table 86. GenScript Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. GenScript Latest Developments
Table 88. Pfizer Inc. Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 89. Pfizer Inc. Recombinant DNA Technology Product Offered
Table 90. Pfizer Inc. Main Business
Table 91. Pfizer Inc. Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Pfizer Inc. Latest Developments
Table 93. Novo Nordisk Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 94. Novo Nordisk Recombinant DNA Technology Product Offered
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Novo Nordisk Latest Developments
Table 98. Sanofi Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 99. Sanofi Recombinant DNA Technology Product Offered
Table 100. Sanofi Main Business
Table 101. Sanofi Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Sanofi Latest Developments
Table 103. Merck KGaA Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 104. Merck KGaA Recombinant DNA Technology Product Offered
Table 105. Merck KGaA Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Merck KGaA Main Business
Table 107. Merck KGaA Latest Developments
Table 108. Profacgen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 109. Profacgen Recombinant DNA Technology Product Offered
Table 110. Profacgen Main Business
Table 111. Profacgen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Profacgen Latest Developments
Table 113. Biocon Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 114. Biocon Recombinant DNA Technology Product Offered
Table 115. Biocon Main Business
Table 116. Biocon Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biocon Latest Developments
Table 118. GlaxoSmithKline Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 119. GlaxoSmithKline Recombinant DNA Technology Product Offered
Table 120. GlaxoSmithKline Main Business
Table 121. GlaxoSmithKline Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. GlaxoSmithKline Latest Developments
Table 123. Cibus Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 124. Cibus Recombinant DNA Technology Product Offered
Table 125. Cibus Main Business
Table 126. Cibus Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Cibus Latest Developments
Table 128. Horizon Discovery Group Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 129. Horizon Discovery Group Recombinant DNA Technology Product Offered
Table 130. Horizon Discovery Group Main Business
Table 131. Horizon Discovery Group Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Horizon Discovery Group Latest Developments
Table 133. New England Biolabs Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 134. New England Biolabs Recombinant DNA Technology Product Offered
Table 135. New England Biolabs Main Business
Table 136. New England Biolabs Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. New England Biolabs Latest Developments
Table 1. Recombinant DNA Technology Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Therapeutic Agent
Table 3. Major Players of Vaccine
Table 4. Major Players of Biotech Crops
Table 5. Major Players of Specialty Chemicals
Table 6. Recombinant DNA Technology Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 9. Recombinant DNA Technology Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 12. Global Recombinant DNA Technology Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Recombinant DNA Technology Revenue Market Share by Player (2018-2023)
Table 14. Recombinant DNA Technology Key Players Head office and Products Offered
Table 15. Recombinant DNA Technology Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Recombinant DNA Technology Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Recombinant DNA Technology Market Size Market Share by Regions (2018-2023)
Table 20. Global Recombinant DNA Technology Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Recombinant DNA Technology Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Recombinant DNA Technology Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Recombinant DNA Technology Market Size Market Share by Country (2018-2023)
Table 24. Americas Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 26. Americas Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 28. APAC Recombinant DNA Technology Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Table 30. APAC Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 32. APAC Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 34. Europe Recombinant DNA Technology Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Recombinant DNA Technology Market Size Market Share by Country (2018-2023)
Table 36. Europe Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 38. Europe Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Recombinant DNA Technology Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Recombinant DNA Technology Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Recombinant DNA Technology Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Recombinant DNA Technology
Table 47. Key Market Challenges & Risks of Recombinant DNA Technology
Table 48. Key Industry Trends of Recombinant DNA Technology
Table 49. Global Recombinant DNA Technology Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Recombinant DNA Technology Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Recombinant DNA Technology Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Recombinant DNA Technology Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Monsanto Company Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 54. Monsanto Company Recombinant DNA Technology Product Offered
Table 55. Monsanto Company Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Monsanto Company Main Business
Table 57. Monsanto Company Latest Developments
Table 58. Roche Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 59. Roche Recombinant DNA Technology Product Offered
Table 60. Roche Main Business
Table 61. Roche Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Roche Latest Developments
Table 63. Biogen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 64. Biogen Recombinant DNA Technology Product Offered
Table 65. Biogen Main Business
Table 66. Biogen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Biogen Latest Developments
Table 68. Amgen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 69. Amgen Recombinant DNA Technology Product Offered
Table 70. Amgen Main Business
Table 71. Amgen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Amgen Latest Developments
Table 73. Novartis Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 74. Novartis Recombinant DNA Technology Product Offered
Table 75. Novartis Main Business
Table 76. Novartis Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Latest Developments
Table 78. Eli Lilly and Company Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 79. Eli Lilly and Company Recombinant DNA Technology Product Offered
Table 80. Eli Lilly and Company Main Business
Table 81. Eli Lilly and Company Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Eli Lilly and Company Latest Developments
Table 83. GenScript Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 84. GenScript Recombinant DNA Technology Product Offered
Table 85. GenScript Main Business
Table 86. GenScript Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. GenScript Latest Developments
Table 88. Pfizer Inc. Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 89. Pfizer Inc. Recombinant DNA Technology Product Offered
Table 90. Pfizer Inc. Main Business
Table 91. Pfizer Inc. Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Pfizer Inc. Latest Developments
Table 93. Novo Nordisk Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 94. Novo Nordisk Recombinant DNA Technology Product Offered
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Novo Nordisk Latest Developments
Table 98. Sanofi Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 99. Sanofi Recombinant DNA Technology Product Offered
Table 100. Sanofi Main Business
Table 101. Sanofi Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Sanofi Latest Developments
Table 103. Merck KGaA Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 104. Merck KGaA Recombinant DNA Technology Product Offered
Table 105. Merck KGaA Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Merck KGaA Main Business
Table 107. Merck KGaA Latest Developments
Table 108. Profacgen Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 109. Profacgen Recombinant DNA Technology Product Offered
Table 110. Profacgen Main Business
Table 111. Profacgen Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Profacgen Latest Developments
Table 113. Biocon Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 114. Biocon Recombinant DNA Technology Product Offered
Table 115. Biocon Main Business
Table 116. Biocon Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Biocon Latest Developments
Table 118. GlaxoSmithKline Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 119. GlaxoSmithKline Recombinant DNA Technology Product Offered
Table 120. GlaxoSmithKline Main Business
Table 121. GlaxoSmithKline Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. GlaxoSmithKline Latest Developments
Table 123. Cibus Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 124. Cibus Recombinant DNA Technology Product Offered
Table 125. Cibus Main Business
Table 126. Cibus Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Cibus Latest Developments
Table 128. Horizon Discovery Group Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 129. Horizon Discovery Group Recombinant DNA Technology Product Offered
Table 130. Horizon Discovery Group Main Business
Table 131. Horizon Discovery Group Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Horizon Discovery Group Latest Developments
Table 133. New England Biolabs Details, Company Type, Recombinant DNA Technology Area Served and Its Competitors
Table 134. New England Biolabs Recombinant DNA Technology Product Offered
Table 135. New England Biolabs Main Business
Table 136. New England Biolabs Recombinant DNA Technology Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. New England Biolabs Latest Developments
LIST OF FIGURES
Figure 1. Recombinant DNA Technology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant DNA Technology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Recombinant DNA Technology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Recombinant DNA Technology Sales Market Share by Country/Region (2022)
Figure 8. Recombinant DNA Technology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Recombinant DNA Technology Market Size Market Share by Type in 2022
Figure 10. Recombinant DNA Technology in Biotechnology and Pharmaceutical Companies
Figure 11. Global Recombinant DNA Technology Market: Biotechnology and Pharmaceutical Companies (2018-2023) & ($ Millions)
Figure 12. Recombinant DNA Technology in Academic & Government Research Institutes
Figure 13. Global Recombinant DNA Technology Market: Academic & Government Research Institutes (2018-2023) & ($ Millions)
Figure 14. Recombinant DNA Technology in Others
Figure 15. Global Recombinant DNA Technology Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Recombinant DNA Technology Market Size Market Share by Application in 2022
Figure 17. Global Recombinant DNA Technology Revenue Market Share by Player in 2022
Figure 18. Global Recombinant DNA Technology Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 20. APAC Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 21. Europe Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 23. Americas Recombinant DNA Technology Value Market Share by Country in 2022
Figure 24. United States Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Recombinant DNA Technology Market Size Market Share by Region in 2022
Figure 29. APAC Recombinant DNA Technology Market Size Market Share by Type in 2022
Figure 30. APAC Recombinant DNA Technology Market Size Market Share by Application in 2022
Figure 31. China Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Recombinant DNA Technology Market Size Market Share by Country in 2022
Figure 38. Europe Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Figure 39. Europe Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Figure 40. Germany Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 54. APAC Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 55. Europe Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 57. United States Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 58. Canada Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 61. China Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 62. Japan Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 63. Korea Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 65. India Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 66. Australia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 67. Germany Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 68. France Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 69. UK Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 70. Italy Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 71. Russia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 72. Spain Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 75. Israel Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 78. Global Recombinant DNA Technology Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant DNA Technology Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Recombinant DNA Technology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Recombinant DNA Technology Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Recombinant DNA Technology Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Recombinant DNA Technology Sales Market Share by Country/Region (2022)
Figure 8. Recombinant DNA Technology Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Recombinant DNA Technology Market Size Market Share by Type in 2022
Figure 10. Recombinant DNA Technology in Biotechnology and Pharmaceutical Companies
Figure 11. Global Recombinant DNA Technology Market: Biotechnology and Pharmaceutical Companies (2018-2023) & ($ Millions)
Figure 12. Recombinant DNA Technology in Academic & Government Research Institutes
Figure 13. Global Recombinant DNA Technology Market: Academic & Government Research Institutes (2018-2023) & ($ Millions)
Figure 14. Recombinant DNA Technology in Others
Figure 15. Global Recombinant DNA Technology Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Recombinant DNA Technology Market Size Market Share by Application in 2022
Figure 17. Global Recombinant DNA Technology Revenue Market Share by Player in 2022
Figure 18. Global Recombinant DNA Technology Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 20. APAC Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 21. Europe Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Recombinant DNA Technology Market Size 2018-2023 ($ Millions)
Figure 23. Americas Recombinant DNA Technology Value Market Share by Country in 2022
Figure 24. United States Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Recombinant DNA Technology Market Size Market Share by Region in 2022
Figure 29. APAC Recombinant DNA Technology Market Size Market Share by Type in 2022
Figure 30. APAC Recombinant DNA Technology Market Size Market Share by Application in 2022
Figure 31. China Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Recombinant DNA Technology Market Size Market Share by Country in 2022
Figure 38. Europe Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Figure 39. Europe Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Figure 40. Germany Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Recombinant DNA Technology Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Recombinant DNA Technology Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 54. APAC Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 55. Europe Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 57. United States Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 58. Canada Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 61. China Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 62. Japan Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 63. Korea Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 65. India Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 66. Australia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 67. Germany Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 68. France Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 69. UK Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 70. Italy Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 71. Russia Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 72. Spain Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 75. Israel Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Recombinant DNA Technology Market Size 2024-2029 ($ Millions)
Figure 78. Global Recombinant DNA Technology Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant DNA Technology Market Size Market Share Forecast by Application (2024-2029)
